1 – 10 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis
- 2017
- Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia
- The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling
- Novel oncogenic noncoding mutations in T-ALL
- Highly variable frequencies of donor antigen-specific naive cells may dictate the immunogenicity of minor histocompatibility antigens after hematopoietic stem cell transplantation
- 2016
- Genomic landscape of pediatric mixed phenotype acute leukemia
- IFM2012-03
- Updated efficacy and safety from the phase 3 resonate-2 study : ibrutinib as first-line treatment option in patients 65 years and older with chronic lymphocytic leukemia/small lymphocytic leukemia
- Impact of age and treatment group in childhood high hyperdiploid low risk B-cell acute lymphoblastic leukemia (ALL) : results of the CLG-EORTC 58951 study
- Prognostic discrimination of children and adolescents with chronic myeloid leukemia based on the EUTOS Long Term Survival (ELTS) score